Bugworks Research Inc, a biopharma startup based in Bangalore, India and Delaware, USA, is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). AMR is a global emergency impacting millions across the world, requiring next-generation novel antibiotics. Bugworks with its years of domain experience and through its innovative approaches has an exciting portfolio of broad-spectrum novel antibiotic assets at various stages of discovery and preclinical development.